We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
776
DELISTED
Natus Medical Inc
NTUS
| $666K | ﹤0.01% |
17,000
+223
| +1% | +$8.37K |
|
|
SCS
777
DELISTED
Steelcase
SCS
| $663K | ﹤0.01% |
39,655
+19,207
| +94% | +$317K |
|
778
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
| $662K | ﹤0.01% |
12,156
| – | – |
|
|
TRCO
779
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $659K | ﹤0.01% |
17,700
-1,800
| -9% | -$61K |
|
780
Williams-Sonoma
WSM
$26.7B
| $658K | ﹤0.01% |
24,572
+4,836
| +25% | +$118K |
|
781
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.44B
| $656K | ﹤0.01% |
23,845
-9,552
| -29% | -$257K |
|
782
Royal Caribbean
RCL
$78.7B
| $654K | ﹤0.01% |
6,670
-657
| -9% | -$61.4K |
|
|
CBM
783
DELISTED
Cambrex Corporation
CBM
| $654K | ﹤0.01% |
11,899
+83
| +0.7% | +$4.43K |
|
784
iShares MSCI ACWI ETF
ACWI
$32.6B
| $653K | ﹤0.01% |
10,334
-1,450
| -12% | -$89.8K |
|
785
Hanmi Financial
HAFC
$943M
| $653K | ﹤0.01% |
21,265
| – | – |
|
786
Cheesecake Factory
CAKE
$4.21B
| $652K | ﹤0.01% |
10,298
+2,458
| +31% | +$150K |
|
787
Commerce Bancshares
CBSH
$8.5B
| $650K | ﹤0.01% |
17,986
+844
| +5% | +$31.1K |
|
788
Darling Ingredients
DAR
$9.93B
| $647K | ﹤0.01% |
44,637
+44,401
| +18,814% | +$585K |
|
|
INN
789
Summit Hotel Properties
INN
$761M
| $646K | ﹤0.01% |
40,488
+365
| +0.9% | +$5.75K |
|
|
WBMD
790
DELISTED
WebMD Health Corp.
WBMD
| $645K | ﹤0.01% |
12,251
-10,391
| -46% | -$531K |
|
791
Bank of Hawaii
BOH
$3.33B
| $643K | ﹤0.01% |
7,824
-300
| -4% | -$25.5K |
|
792
Axos Financial
AX
$5.45B
| $642K | ﹤0.01% |
24,594
| – | – |
|
793
Brady Corp
BRC
$4.45B
| $642K | ﹤0.01% |
16,648
| – | – |
|
794
iShares Biotechnology ETF
IBB
$9.31B
| $642K | ﹤0.01% |
6,576
+2,220
| +51% | +$213K |
|
|
CSII
795
DELISTED
Cardiovascular Systems, Inc.
CSII
| $639K | ﹤0.01% |
+22,629
| New | +$601K |
|
796
EXL Service
EXLS
$4.23B
| $638K | ﹤0.01% |
67,430
| – | – |
|
|
FMBI
797
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $637K | ﹤0.01% |
26,948
+1,709
| +7% | +$41.6K |
|
798
Argan
AGX
$7.98B
| $635K | ﹤0.01% |
9,611
+110
| +1% | +$7.7K |
|
799
Vanguard Small-Cap Growth ETF
VBK
$23.2B
| $629K | ﹤0.01% |
4,481
+20
| +0.4% | +$2.77K |
|
800
Alamo Group
ALG
$2.01B
| $628K | ﹤0.01% |
+8,250
| New | +$630K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.